Breaching Biological Barriers: Protein Translocation Domains as Tools for Molecular Imaging and Therapy

Molecular Imaging

Volumn 2, Issue 4, 2003, Pages 313-323

  Franc, Benjamin J ^a   Mandl, Stefanie J ^b   Siprashvili, Zurab ^b   Wender, Paul ^b   Contag, Christopher H ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Cell penetrating peptide; Cell trafficking; Imaging; Protein transduction domain; Reporter gene

Indexed keywords

CELL PENETRATING PEPTIDES; CELL TRAFFICKING; PROTEIN TRANSDUCTION DOMAINS (PTD); REPORTER GENES;

BIOCHEMISTRY; CELLS; DNA; GENES; LIPIDS; MAGNETIC MATERIALS; NANOSTRUCTURED MATERIALS; POLYPEPTIDES; PROTEINS; VIRUSES;

MEDICAL IMAGING;

PROTEIN;

ANIMAL; GENETICS; HUMAN; MACROMOLECULE; METABOLISM; METHODOLOGY; MOLECULAR BIOLOGY; PHYSIOLOGY; PROTEIN TERTIARY STRUCTURE; PROTEIN TRANSPORT; REPORTER GENE; REVIEW;

ANIMALS; GENES, REPORTER; HUMANS; MACROMOLECULAR SUBSTANCES; MOLECULAR BIOLOGY; PROTEIN STRUCTURE, TERTIARY; PROTEIN TRANSPORT; PROTEINS;

EID: 1642434448     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.1162/153535003322750655     Document Type: Review

References (97)

1. Han K, Jeon MJ, Kim SH, Ki D, Bahn JH, Lee KS, Park J, Choi SY (2001). Efficient intracellular delivery of an exogenous protein GFP with genetically fused basic oligopeptides. Mol Cells. 12:267-271.
2. Torchilin VP, Lukyanov AN (2003). Peptide and protein drug delivery to and into tumors: Challenges and solutions. Drug Discov Today. 8:259-266.
3. Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SF (1999). In vivo protein transduction: Delivery of a biologically active protein into the mouse, Science. 285:1569-1572.
4. Wadia JS, Dowdy SF (2002). Protein transduction technology. Curr Opin Biotechnol. 13:52-56.
5. Wender PA, Mitchell DJ, Pattabiraman K, Pelkey ET, Steinman L, Rothbard JB (2000). The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: Peptoid molecular transporters. Proc Natl Acad Sci USA. 97:13003-13008.
6. Rothbard JB, Kreider E, VanDeusen CL, Wright L, Wylie BL, Wender PA (2002). Arginine-rich molecular transporters for drug delivery: Role of backbone spacing in cellular uptake. J Med Chem. 45:3612-3618.
7. Torchilin VP, Rammohan R, Weissig V, Levchenko TS (2001). TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc Nail Acad Sci USA. 98:8786-8791.
8. Park J, Ryu J, Kim KA, Lee HJ, Bahn JH, Han K, Choi EY, Lee KS, Kwon HY, Choi SY (2002). Mutational analysis of a human immunodeficiency virus type 1 Tat protein transduction domain which is required for delivery of an exogenous protein into mammalian cells. J Gen Virol. 83:1173-1181.
9. Han K, Jeon MJ, Kim KA, Park J, Choi SY (2000). Efficient intracellular delivery of GFP by homeodomains of Drosophila Fushi-tarazu and Engrailed proteins. Mol Cells. 10:728-732.
10. Schwarze SR, Dowdy SF (2000). In vivo protein transduction: Intracellular delivery of biologically active proteins, compounds and DNA. Trends Pharmacol Sci. 21:45-48.
11. Schwarze SR, Hruska KA, Dowdy SF (2000). Protein transduction: Unrestricted delivery into all cells? Trends Cell Biol. 10:290-295.
12. Elliott G, O'Hare P (1997). Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell. 88:223-233.
13. Midoux P, Monsigny M (1999). Efficient gene transfer by histidylated polylysine/pDNA complexes. Bioconjug Chem. 10:406-411.
14. Morris MC, Depollier J, Mery J, Heitz F, Divita G (2001). A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat Biotechnol. 19:1173-1176.
15. Futaki S, Ohashi W, Suzuki T, Niwa M, Tanaka S, Ueda K, Harashima H, Sugiura Y (2001). Stearylated arginine-rich peptides: A new class of transfection systems. Bioconjug Chem. 12:1005-1011.
16. Ho A, Schwarze SR, Mermelstein SJ, Waksman G, Dowdy SF (2001). Synthetic protein transduction domains: Enhanced transduction potential in vitro and in vivo. Cancer Res. 61:474-477.
17. Wender PA, Jessop TC, Pattabiraman K, Pelkey ET, Van Deusen CL (2001). An efficient, scalable synthesis of the molecular transporter octaarginine via a segment doubling strategy. Org Lett. 3:3229-3232.
18. McKenzie DL, Smiley E, Kwok KY, Rice KG (2000). Low molecular weight disulfide cross-linking peptides as nonviral gene delivery carriers. Bioconjug Chem. 11:901-909.
19. Hawinger (1999). Non-invasive intracellular delivery of functional peptides and proteins. Curr Opin Chem Biol. 3:89-94.
20. Snyder EL, Dowdy SF (2001). Protein/peptide transduction domains: Potential to deliver large DNA molecules into cells. Curr Opin Mol Ther. 3:147-152.
21. Prochiantz A (2000). Messenger proteins: Homeoproteins, TAT, others. Curr Opin Cell Biol. 12:400-406.
22. Derossi D, Chassaing G, Prochiantz A (1998). Trojan peptides: the penetratin system for intracellular delivery. Trends Cell Biol. 8:84-87.
23. Chan DA, Yun Z, Denko NC, Giaccia AJ (2002). Analysis of HIV tat-mediated protein transduction: a potential therapeutic. Proc Am Assoc Cancer Res. 43:947.
24. Rothbard JB, Garlington S, Lin Q, Kirschberg T, Kreider E, McGrane PL, Wender PA, Khavari PA (2000). Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation. Nat Med. 6:1253-1257.
25. Gammon ST, Villalobos VM, Prior JL, Sharma V, Piwnica-Worms D (2003). Quantitative analysis of permeation peptide complexes labeled with technetium-99m: Chiral and sequence-specific effects on net cell uptake. Bioconjug Chem. 14:368-376.
26. Mai JC, Shen H, Watkins SC, Cheng T, Robbins PD (2002). Efficiency of protein transduction is cell type-dependent and is enhanced by dextran sulfate. J Biol Chem. 277:30208-30218.
27. Siprashvili Z, Scholl FA, Oliver SF, Adams A, Contag CH, Wender PA, Khavari PA (2003). Gene transfer via reversible plasmid condensation with cysteine-flanked, internally spaced arginine-rich peptides. Hum Gene Ther. 14:1225-1233.
28. Chen L, Wright LR, Chen CH, Oliver SF, Wender PA, Mochly-Rosen D (2001). Molecular transporters for peptides: Delivery of a cardioprotective epsilonPKC agonist peptide into cells and intact ischemic heart using a transport system, R(7). Chem Biol. 8:1123-1129.
29. Pepinsky RB, Androphy EJ, Corina K, Brown R, Barsoum J (1994). Specific inhibition of a human papillomavirus E2 trans-activator by intracellular delivery of its repressor. DNA Cell Biol. 13:1011-1019.
30. Nagahara H, Vocero-Akbani AM, Snyder EL, Ho A, Latham DG, Ussy NA, Becker-Hapak M, Ezhevsky SA, Dowdy SF (1998). Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kipl induces cell migration. Nat Med. 4: 1449-1452.
31. Vocero-Akbani A, Chellaiah MA, Hruska KA, Dowdy SF (2001). Protein transduction: Delivery of Tat-GTPase fusion proteins into mammalian cells. Methods Enzymol. 332:36-49.
32. Vocero-Akbani AM, Heyden NV, Lissy NA, Ratner L, Dowdy SF (1999). Killing HIV-infected cells by transduction with an HIV protease-activated caspase-3 protein. Nat Med. 5:29-33.
33. Vocero-Akbani A, Lissy NA, Dowdy SF (2000). Transduction of full-length Tat fusion proteins directly into mammalian cells: Analysis of T cell receptor activation-induced cell death. Methods Enzymol. 322:508-521.
34. Yoon HY, Lee SH, Cho SW, Lee JE, Yoon CS, Park J, Kim TU, Choi SY (2002). TAT-mediated delivery of human glutamate dehydrogenase into PC12 cells. Neurochem Int. 41:37-42.
35. Josephson L, Tung CH, Moore A, Weissleder R (1999). High-efficiency intracellular magnetic labeling with novel superpara-magnetic-Tat peptide conjugates. Bioconjug Chem. 10:186-191.
36. Polyakov V, Sharma V, Dahlheimer JL, Pica CM, Luker GD, Piwnica-Worms D (2000). Novel Tat-peptide chelates for direct transduction of technetium-99m and rhenium into human cells for imaging and radiotherapy. Bioconjug Chem. 11:762-771.
37. Torchilin VP (2002). TAT peptide-modified liposomes for intracellular delivery of drugs and DNA. Cell Mol Biol Lett. 7:265-267.
38. Bonifaci N, Sitia R, Rubartelli A (1995). Nuclear translocation of an exogenous fusion protein containing HIV Tat requires unfolding. Aids. 9:995-1000.
39. Kwon HY, Eum WS, Jang HW, Kang JH, Ryu J, Ryong Lee B, Jin LH, Park J, Choi SY (2000). Transduction of Cu,Zn-superoxide dismutase mediated by an HIV-1 Tat protein basic domain into mammalian cells. FEBS Lett. 485:163-167.
40. Tung CH, Mueller S, Weissleder R (2002). Novel branching membrane translocational peptide as gene delivery vector. Bioorg Med Chem. 10:3609-3614.
41. Suzuki T, Futaki S, Niwa M, Tanaka S, Ueda K, Sugiura Y (2002). Possible existence of common internalization mechanisms among arginine-rich peptides. J Biol Chem. 277:2437-2443.
42. Silhol M, Tyagi M, Giacca M, Lebleu B, Vives E (2002). Different mechanisms for cellular internalization of the HIV-1 Tat-derived cell penetrating peptide and recombinant proteins fused to Tat. Eur J Biochem. 269:494-501.
43. Tyagi M, Rusnati M, Presta M, Giacca M (2001). Internalization of HIV-1 tat requires cell surface heparan sulfate proteoglycans. J Biol Chem. 276:3254-3261.
44. Phelps ME (2000). Inaugural article: Positron emission tomography provides molecular imaging of biological processes. Proc Natl Acad Sci USA. 97:9226-9233.
45. Jacobs RE, Ahrens ET, Meade TJ, Fraser SE (1999). Looking deeper into vertebrate development. Trends Cell Biol. 9:73-76.
46. Sharma V, Luker GD, Piwnica-Worms D (2002). Molecular imaging of gene expression and protein function in vivo with PET, SPECT. J Magan Reson Imaging. 16:336-351.
47. Contag CH, Ross BD (2002). It's not just about anatomy: In vivo bioluminescence imaging as an eyepiece into biology. J Magn Reson Imaging. 16:378-387.
48. Contag CH, Bachmann MH (2002). Advances in in vivo bioluminescence imaging of gene expression. Annu Rev Biomed Eng. 4:235-260.
49. Gambhir SS, Barrio JR, Herschman HR, Phelps ME (1999). Assays for noninvasive imaging of reporter gene expression. Nucl Med Biol. 26:481-490.
50. Gambhir SS, Barrio JR, Phelps ME, Iyer M, Namavari M, Satyamurthy N, Wu L, Green LA, Bauer E, MacLaren DC, Nguyen K, Berk AJ, Cherry SR, Herschman HR (1999). Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. Proc Natl Acad Sci USA. 96:2333-2338.
51. Gambhir SS, Herschman HR, Cherry SR, Barrio JR, Satyamurthy N, Toyokuni T, Phelps ME, Larson SM, Balatoni J, Finn R, Sadelain M, Tjuvajev J, Blasberg R (2000). Imaging transgene expression with radionuclide imaging technologies. Neoplasia. 2:118-138.
52. Mandl S, Schimmelpfennig C, Edinger M, Negrin RS, Contag CH (2002). Understanding immune cell trafficking patterns via in vivo bioluminescence imaging. J Cell Biochem Suppl. 39:239-248.
53. Mai JC, Mi Z, Kim SH, Ng B, Robbins PD (2001). A proapoptotic peptide for the treatment of solid tumors. Cancer Res. 61: 7709-7712.
54. Harada H, Hiraoka M, Kizaka-Kondoh S (2002). Antitumor effect of TAT-oxygen-dependent degradation-caspase-3 fusion protein specifically stabilized and activated in hypoxic tumor cells. Cancer Res. 62:2013-2018.
55. Shibagaki N, Udey MC (2002). Dendritic cells transduced with protein antigens induce cytotoxic lymphocytes and elicit antitumor immunity. J Immunol. 168:2393-2401.
56. Cao G, Pei W, Ge H, Liang Q, Luo Y, Sharp FR, Lu A, Ran R, Graham SH, Chen J (2002). In vivo delivery of a Bcl-xL fusion protein containing the TAT protein transduction domain protects against ischemic brain injury and neuronal apoptosis. J Neurosci. 22:5423-5431.
57. Gustafsson AB, Sayen MR, Williams SD, Crow MT, Gottlieb RA (2002). TAT protein transduction into isolated perfused hearts: TAT-apoptosis repressor with caspase recruitment domain is cardioprotective. Circulation. 106:735-739.
58. Dodd CH, Hsu HC, Chu WJ, Yang P, Zhang HG, Mountz JD, Jr., Zinn K, Forder J, Josephson L, Weissleder R, Mountz JM, Mountz JD (2001). Normal T-cell response and in vivo magnetic resonance imaging of T cells loaded with HIV transactivator-peptide-derived superparamagnetic nanoparticles. J Immunol Methods. 256:89-105.
59. Kircher MF, Allport JR, Graves EE, Love V, Josephson L, Lichtman AH, Weissleder R (2003). In vivo high resolution three dimensional imaging of antigen-specific cytotoxic T-lymphcyte trafficking to tumors. Cancer Res. (in press).
60. Lewin M, Carlesso N, Tung CH, Tang XW, Cory D, Scadden DT, Weissleder R (2000). Tat peptide-derivatized magnetic nano-particles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol. 18:410-414.
61. Zhao M, Kircher MF, Josephson L, Weissleder R (2002). Differential conjugation of tat peptide to superparamagnetic nano-particles and its effect on cellular uptake. Bioconjug Chem. 13: 840-844.
62. Allen MJ, Meade TJ (2003). Synthesis and visualization of a membrane-permeable MRI contrast agent. J Biol Inorg Chem. 11: 301-305.
63. Bhorade R, Weissleder R, Nakakoshi T, Moore A, Tung CH (2000). Macrocyclic chelators with paramagnetic cations are internalized into mammalian cells via a HIV-tat derived membrane translocation peptide. Bioconjug Chem. 11:301-305.
64. Xia H, Mao Q, Davidson BL (2001). The HIV Tat protein transduction domain improves the biodistribution of beta-glucuronidase expressed from recombinant viral vectors. Nat Biotechnol 19:640-644.
65. Chittchang M, Salamat-Miller N, Alur HH, VanderVelde DG, Mitra AK, Johnston TP (2002). Poly(L-lysine) as a model drug macro-molecule with which to investigate secondary structure and microporous membrane transport: Part 2. Diffusion studies. J Pharm Pharmacol 54:1497-1505.
66. Robbins PB, Oliver SF, Sheu SM, Goodnough JB, Wender P, Khavari PA (2002). Peptide delivery to tissues via reversibly linked protein transduction sequences. BioTechniques. 33:190-192, 194.
67. Siprashveli Z, Scholl F, Oliver S, Wender PA, Khavari PA (2003). Gene transfer via reversible plasmid condensation with protein transduction domains. (in press).
68. Emi N, Kidoaki S, Yoshikawa K, Saito H (1997). Gene transfer mediated by polyarginine requires a formation of big carrier-complex of DNA aggregate. Biochem Biophys Res Commun. 231:421-424.
69. Park Y, Kwok KY, Boukarim C (2002). Synthesis of sulfhydryl cross-linking poly(ethylene glycol)-peptides and glycopeptides as carriers for gene delivery. Bioconjugate Chemistry. 13:232-239.
70. Kwok KY, McKenzie DL, Evers DL, Rice KG (1999). Formulation of highly soluble poly(ethylene glycol)-peptide DNA condensates. J Pharm Sci. 88:996-1003.
71. Collard WT, Evers DL, McKenzie DL, Rice KG (2000). Synthesis of homogeneous glycopeptides and their utility as DNA condensing agents. Carbohydr Res. 323:176-184.
72. Collard WT, Yang Y, Kwok KY, Park Y, Rice KG (2000). Biodistribution, metabolism, and in vivo gene expression of low molecular weight glycopeptide polyethylene glycol peptide DNA co-condensates. J Pharm Sci. 89:499-512.
73. Blessing T, Remy JS, Behr JP (1998). Monomolecular collapse of plasmid DNA into stable virus-like particles. Proc Natl Acad Sci USA. 95:1427-1431.
74. Trubetskoy VS, Loomis A, Slattum PM, Hagstrom JE, Budker VG, Wolff JA (1999). Caged DNA does not aggregate in high ionic strength solutions. Bioconjug Chem. 10:624-628.
75. McKenzie DL, Kwok KY, Rice KG (2000). A potent new class of reductively activated peptide gene delivery agents. J Biol Chem. 275:9970-9977.
76. Adami RC, Collard WT, Gupta SA, Kwok KY, Bonadio J, Rice KG (1998). Stability of peptide-condensed plasmid DNA formulations. J Pharm Sci. 87:678-683.
77. Rudolph C, Plank C, Lausier J, Schillinger U, Muller RH, Rosenecker J (2003). Oligomers of the arginine-rich motif of the HTV-1 TAT protein are capable of transferring plasmid DNA into cells. J Biol Chem.
78. Park J, Ryu J, Jin LH, Bahn JH, Kim JA, Yoon CS, Kim DW, Han KH, Eum WS, Kwon HY, Kang TC, Won MH, Rang JH, Cho SW, Choi SY (2002). 9-polylysine protein transduction domain: Enhanced penetration efficiency of Superoxide dismutase into mammalian cells and skin. Mol Cells. 13:202-208.
79. Zanta MA, Belguise-Valladier P, Behr JP (1999). Gene delivery: A single nuclear localization signal peptide is sufficient to carry DMA to the cell nucleus. Proc Nail Acad Sci USA. 96:91-96.
80. Sebestyen MG, Ludtke JJ, Bassik MC, Zhang G, Budker V, Lukhtanov EA, Hagstrom JE, Wolff JA (1998). DNA vector chemistry: the covalent attachment of signal peptides to plasmid DNA. Nat Biotechnol. 16:80-85.
81. Joshi SK, Hashimoto K, Koni PA (2002). Induced DNA recombination by Cre recombinase protein transduction. Genesis. 33:48-54.
82. Jo D, Nashabi A, Doxsee C, Lin Q, Unutmaz D, Chen J, Ruley HE (2001). Epigenetic regulation of gene structure and function with a cell-permeable Cre recombinase. Nat Biotechnol. 19: 929-933.
83. Olivares EC, Hollis RP, Calos MP (2001). Phage R4 integrase mediates site-specific integration in human cells. Gene. 278: 167-176.
84. Sclimenti CR, Thyagarajan B, Calos MP (2001). Directed evolution of a recombinase for improved genomic integration at a native human sequence. Nucleic Acids Res. 29:5044-5051.
85. Will E, Klump H, Heffner N, Schwieger M, Schiedlmeier B, Ostertag W, Baum C, Stocking C (2002). Unmodified Cre recombinase crosses the membrane. Nucleic Acids Res. 30:e59.
86. McKenzie DL, Collard WT, Rice KG (1999). Comparative gene transfer efficiency of low molecular weight polylysine DNA-condensing peptides. J Pept Res. 54:311-318.
87. Wunderbaldinger P, Josephson L, Weissleder R (2002). Tat peptide directs enhanced clearance and hepatic permeability of magnetic nanoparticles. Bioconjug Chem. 13:264-268.
88. Bullok KE, Dyszlewski M, Prior JL, Pica CM, Sharma V, Piwnica-Worms D (2002). Characterization of novel histidine-tagged tat-peptide complexes dual-labeled with (99m)tc-tricarbonyl and fluorescein for scintigraphy and fluorescence microscopy. Bioconjug Chem. 13:1226-1237.
89. Johansson BR, Karlsson R, Bagge U (1983). Utrastructural observations on endothelial cell vesicles after horseradish peroxidase microinjection into blood and dextran perfused microvessels of rat mesentery. Int J Microcirc Clin Exp. 2:157-169.
90. Embury J, Klein D, Pileggi A, Ribeiro M, Jayaraman S, Molano RD, Fraker C, Kenyon N, Ricordi C, Inverardi L, Pastori RL (2001). Proteins linked to a protein transduction domain efficiently transduce pancreatic islets. Diabetes. 50:1706-1713.
91. Gius DR, Ezhevsky SA, Becker-Hapak M, Nagahara H, Wei MC, Dowdy SF (1999). Transduced p161NK4a peptides inhibit hypophosphorylation of the retinoblastoma protein and cell cycle progression prior to activation of Cdk2 complexes in late G1. Cancer Res. 59:2577-2580.
92. Jin LH, Bahn JH, Hum WS, Kwon HY, Jang SH, Han KH, Kang TC, Won MH, Kang JH, Cho SW, Park J, Choi SY (2001). Transduction of human catalase mediated by an HIV-1 TAT protein basic domain and arginine-rich peptides into mammalian cells. Free Radic Biol Med. 31:1509-1519.
93. Li H, Yao Z, Degenhardt B, Teper G, Papadopoulos V (2001). Cholesterol binding at the cholesterol recognition/interaction amino acid consensus (CRAG) of the peripheral-type benzodia-zepine receptor and inhibition of steroidogenesis by an HIV TAT-CRAC peptide. Proc Natl Acad Sci USA 98:1267-1272.
94. Futaki S, Suzuki T, Ohashi W, Yagami T, Tanaka S, Ueda K, Sugiura Y (2001). Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery. J Biol Chem. 276:5836-5840.
95. Elfgang C, Rosorius O, Hofer L, Jaksche H, Hauber J, Bevec D (1999). Evidence for specific nucleocytoplasmic transport path-ways used by leucine-rich nuclear export signals. Proc Natl Acad Sci USA. 96:6229-6234.
96. Matsushita M, Tomizawa K, Moriwaki A, Li ST, Terada H, Matsui H (2001). A high-efficiency protein transduction system demonstrating the role of PKA in long-lasting long-term potentiation. J Neurosci. 21:6000-6007.
97. Wender PA, Rothbard JB, Jessop TC, Kreider EL, Wylie BL (2002). Oligocarbamate molecular transporters: Design, synthesis, and biological evaluation of a new class of transporters for drug delivery. J Am Chem Soc. 124:13382-13383.